Geopolitics Alpha

Market closed · last trade · ETFs, Alpaca IEX

8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)

Published . Updated .

Key takeaways

  • 8-K/A - Voyager Therapeutics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
  • Exposed: VYGR
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHA8-K/A - Voyager Therapeutics, Inc.(0001640266) (Filer)VYGRGEOPOLITICS ALPHA

8-K/A - Voyager Therapeutics filed an 8-K with the SEC on Nov 18 (a notice of a material company event).

Directly affected

  • VYGR Voyager Therapeutics-14.2% 12d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Voyager Therapeutics belongs to, so it often moves with news about it.

  • AMGN Amgen+15.9% 30d

    Amgen is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • GILD Gilead Sciences+16.4% 30d

    Gilead Sciences is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • MRNA Moderna+22.4% 30d

    Moderna is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • ARGX argenx SE-11.9% 9d

    argenx SE is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • RVMD Revolution Medicines

    Revolution Medicines is a peer of Voyager Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
VYGR+1.80%-2.99%baseafter closeafter closeafter closeafter close
XLV+3.66%+3.71%baseafter closeafter closeafter closeafter close
AMGN+5.25%+4.18%baseafter closeafter closeafter closeafter close
GILD-0.60%-0.81%baseafter closeafter closeafter closeafter close
MRNA+17.58%+9.45%baseafter closeafter closeafter closeafter close
ARGX+4.21%+1.05%baseafter closeafter closeafter closeafter close
RVMD+10.32%+4.32%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-18 AccNo: 0001193125-26-467226 Size: 247 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

The price since 18 Nov 2026: Voyager Therapeutics (VYGR) versus the S&P 500

CompanyWhenMoveStatus
AMGNthree days earlier+4.18%final price
AMGNfive days earlier+5.25%final price
ARGXthree days earlier+1.05%final price
ARGXfive days earlier+4.21%final price
GILDthree days earlier-0.81%final price
GILDfive days earlier-0.60%final price
MRNAthree days earlier+9.45%final price
MRNAfive days earlier+17.58%final price
RVMDthree days earlier+4.32%final price
RVMDfive days earlier+10.32%final price
Voyager Therapeutics (VYGR)three days earlier-2.99%final price
Voyager Therapeutics (VYGR)five days earlier+1.80%final price
XLVthree days earlier+3.71%final price
XLVfive days earlier+3.66%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Voyager Therapeutics (VYGR)

Companies mentioned with this story

  • VYGR Voyager Therapeutics

    For “8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer),” Voyager Therapeutics (VYGR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VYGR

How “8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” reaches Voyager Therapeutics (VYGR)

“8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” (18 Nov 2026) reaches Voyager Therapeutics (VYGR) through this story.

Voyager Therapeutics (VYGR) is on the page because SEC 8-K filing -> direct issuer disclosure -> VYGR

The price range for Voyager Therapeutics (VYGR), and the dates in the story

VYGR traded between 1.68 and 2.29 across 12 sessions. The latest close on file is 1.88.

How strong the case is around Voyager Therapeutics (VYGR)

14 out of 100

“8-K/A - Voyager Therapeutics, Inc. (0001640266) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.